期刊文献+

2型糖尿病患者血清透明质酸与颈动脉内膜中层厚度的相关性研究

Correlation between serum hyaluronic acid and carotid intima media thickness in patients with type 2 diabetes mellitus
下载PDF
导出
摘要 目的探讨2型糖尿病(T2DM)患者血清透明质酸(HA)与颈动脉内膜中层厚度(CIMT)的相关性,以明确血清HA在T2DM大血管病变中的实验室诊断价值。方法选取我院T2DM患者144例,其中T2DM无并发症组33例,T2DM大血管并发症组47例,T2DM非大血管并发症组64例,另选健康体检者30例作为健康对照组(NC组)。测定血清HA、CIMT、超敏C反应蛋白(hs-CRP)、血脂、空腹血糖水平。结果 T2DM无并发症组、T2DM大血管并发症组、T2DM非大血管并发症组血清HA均高于NC组(P<0.05);T2DM大血管并发症组血清HA显著高于T2DM非大血管并发症组和T2DM无并发症组(P<0.01);血清HA与FPG、Hb A1c、HOMA-IR及CIMT呈正相关(r=0.853、0.711、0.779、0.328,P均<0.01),与HDL-C呈负相关(r=-0.749,P=0.000);CIMT与HA、FPG、Hb A1c、HOMA-IR及hs-CRP呈正相关(r=0.328、0.404、0.384、0.361、0.180,P<0.05),与HDL-C呈负相关(r=-0.303,P=0.000)。结论 T2DM及其血管并发症患者血清HA显著升高,且血清HA升高水平和CIMT显著相关,可能与糖代谢紊乱导致血管损伤影响细胞外基质HA产生有关,血清HA可以作为T2DM及其大血管并发症的辅助诊断指标。 Objective To investigate the correlation between serum hyaluronic acid(HA) and carotid intima-media thickness(CIMT) in patients with type 2 diabetes mellitus(T2DM), and to determine the diagnostic value of serum HA in the laboratory diagnosis of T2 DM and its vascular complications. Methods 144 cases of T2 DM patients in our hospital were selected, including 33 cases of T2 DM without complications, 47 cases of T2 DM macrovascular complications, 64 cases of non macrovascular complications of T2 DM. 30 cases of healthy persons were selected as healthy control group(NC group). The serum levels of HA, CIMT, high sensitive C reactive protein(hs-CRP), blood lipid and fasting blood glucose were measured. Results The serum levels of HA in T2 DM without complications group, T2 DM with macrovascular complications group, non macrovascular complications group were higher than that of NC group(P〈0.05); Serum HA in T2 DM macrovascular complications group was significantly higher than that of non macroangiopathy group and T2 DM without complications group(P〈0.01); Serum HA was positively correlated with FPG, Hb A1 c, HOMA-IR and CIMT(r=0.853, 0.711, 0.779, 0.328, P〈0.01), and negatively correlated with HDL-C(r=-0.749, P=0.000); CIMT was positively correlated with HA, FPG, Hb A1 c, HOMA-IR and hs-CRP(r=0.328, 0.404, 0.384, 0.361, 0.180, P〈0.05), and negatively correlated with HDL-C(r=-0.303, P=0.000). Conclusion Serum HA significantly increased in patients with T2 DM and its vascular complications, and elevated serum levels of HA and it had significantly correlation with CIMT. These may be related to the disorder of glucose metabolism and effect on HA of the ex-tracellular matrix, and serum HA can be used as an assistant diagnostic index for T2 DM and its vascular complications.
作者 杨兴文 李伟华 吕亚亚 史少林 董莉 李元 权金星 YangXingwen Li Weihua Lv Yaya et al(Department of Clinical Laboratory Medicine,Ningxia Medical University,Yinchuan 75000)
出处 《中国现代医药杂志》 2016年第9期1-4,共4页 Modern Medicine Journal of China
基金 国家自然科学基金委员会资助项目(编号:81460155 81260136 30960147)
关键词 透明质酸 糖尿病 血管并发症 动脉粥样硬化 颈动脉内膜中层厚度 Hyaluronic acid Diabetes mellitus Vessel complication Atherosclerosis Carotid intima-media thickness
  • 相关文献

参考文献6

二级参考文献35

  • 1周翔海,纪立农.空腹血糖和糖化血红蛋白用于筛查糖尿病的研究[J].中华糖尿病杂志(1006-6187),2005,13(3):203-205. 被引量:157
  • 2陈清棠 主编.临床神经病学[M].北京:北京科学技术出版社,2002.178.
  • 3The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. N Engl J Med,1993,329:977-986.
  • 4UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet, 1998,352.:837-853.
  • 5Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complica tions in Japanese patients with non-insulin-dependent diabetes mellitus; a randomized prospective 6-year study. Diabetes Res Clin Pratt,1995,28 ; 103-117.
  • 6Turner RC, Milns H, Neil HA, et al. Risk factors for coronary artery disease in non insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS.. 23). BMJ, 1998, 316:823-828.
  • 7The ADVANCE collaborative group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med,2008,358:2560 2572.
  • 8The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med,2008,358.-2545-2559.
  • 9Holman RR, Sanjoy KP, Bethel MA, et al. 10 Year Follow-up of intensive glucose control in type 2 diabetes. N Engl J Med, 2008,359 : 1577-1589.
  • 10Bakris GL, Ruilope LM, McMorn SO, et al. Rosiglitazone reduces microalbuminuria and blood pressure independently of glycemia in type 2 diabetes patients with microalbuminuria. J Hypertens, 2006,24:2047-2055.

共引文献901

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部